The clinical explanation for why diets stop working, and what actually does

There is a pattern that many women recognise: years of careful eating, consistent exercise, and tracking, with results that either never arrive or disappear as quickly as they appear. The STEP research program studied this exact group, and what they found was not about diet quality. It was about the brain.

What the research found

The Study

STEP Program, Semaglutide Treatment Effect in People with Obesity

Randomised, double-blind, placebo-controlled. Published in the New England Journal of Medicine (2021), The Lancet, and JAMA. 45,000+ participants across 68 countries, primarily women aged 35 to 60 with documented weight-loss resistance.

The hypothalamus, which receives the body's fullness signal, was either getting it too late or suppressing it. The clinical term is satiety signalling impairment. The lived experience is constant hunger that has nothing to do with how much you have eaten, and a preoccupation with food that feels impossible to control.

"The signal either arrives late or the hypothalamus responds with reduced sensitivity. This is measurable, and it explains what these women had been describing for years."

STEP Trial Summary, New England Journal of Medicine, 2021

What they were prescribed

Medication	Average loss	20%+ outcomes	Method
Semaglutide	-15.3%	22% of group	Weekly injection or oral
Tirzepatide, strongest results	-22.5%	32% of group	Weekly injection
Diet and exercise only	-2.4%	2% of group

The protocol that produced the best results

FOUR CONSISTENT HABITS, BEST-OUTCOME GROUP

• 1
  Weekly clinician-prescribed GLP-1 injection (semaglutide or tirzepatide), dose-adjusted every four weeks by a licensed physician.
• 2
  30 to 40g protein per meal. Not calorie restriction. The single most effective dietary change for preserving lean mass in the study data.
• 3
  A 30-minute walk every day. The most consistent habit among those who kept results after the study ended, because it asks nothing extraordinary.
• 4
  Physician check-ins every four to eight weeks for dose adjustments. Built into the programme.

Clinician-prescribed GLP-1 is available through TrimRx. Free eligibility check, no payment required.

Start free check

The clinical picture

Assessment

Consistent effort with no result for years points to biology, not behaviour. GLP-1 medications are the only intervention shown to address the mechanism directly. A 160-pound woman averaged 24 pounds lost at six months. These are averages across all 45,000 participants, not selected cases.

How the cost changed

Brand-name GLP-1 medications retail above $1,000 a month. TrimRx works with FDA-registered compounding pharmacies to provide the same active compounds, clinician-prescribed, pharmaceutical standards, doctor-supervised.

Brand-name retail

$1,300+

Per month, no insurance

vs

TrimRx programme

OK

Clinician-prescribed, FDA-reg. pharmacy

Same active compounds. Pharmaceutical standards. Doctor-supervised. Free delivery.

Free Assessment

Start the free TrimRx eligibility check

If your profile matches the study, prior diet resistance, hormonal shifts, biological hunger, you likely qualify. A licensed clinician reviews every submission.

Same active compounds

Clinician-prescribed

FDA-registered pharmacy

Free delivery

No insurance needed

Cancel anytime

Start free eligibility check

No payment at assessment stage · Physician-reviewed · US residents only

Disclosure: sponsored content in partnership with TrimRx. Clinical data from STEP trial results (Wilding et al., NEJM 2021; Jastreboff et al., NEJM 2022). Average outcomes do not guarantee individual results. Compounded medications are not FDA-approved as finished drug products. Programme requires physician oversight. Individual results vary.

Registered Company

WAFFLE ADVERTISING LTD

Registered address: 85 Great Portland Street, London, W1W 7LT, United Kingdom